Clinical Trial Update: Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea [Phase 4]

View source ↗

Summary

Clinical trial investigating Dextenza versus topical fluorometholone in ocular rosacea was withdrawn during Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Rosacea

Drugs mentioned

• Dextenza (Dexamethasone)

Snippet

Sponsor: Eye Associates of Central Texas | Conditions: Ocular Rosacea | Phase 4 | Status: WITHDRAWN